Since semaglutides patent expired in India in March 2026, generic versions have cut monthly costs by roughly 80%, making these GLP-1 medications far more accessible for Indias 100+ million people with diabetes and 250 million people who are overweight or obese
Gia Eapen, MD, elaborates, It works by raising brain chemicals like norepinephrine and dopamine, which help control hunger signals and food cravings
J., Bckhed, F., & Olofsson, L
Small studies are less conclusive than big ones with hundreds of patients
Here are some actionable steps: Schedule your switch during a calm stretch so you can focus on monitoring how you feel
Note: Epithalon is not approved by the FDA for medical use